Inside a Seattle lab working to develop a COVID-19 vaccine

‘We’ve put a lot of projects on hold so that we can focus on this.’

 

In a tall building on the outskirts of downtown Seattle, a group of scientists from the University of Washington’s Institute for Protein Design huddle in front of computers, concentrating on their screens. Using a special program, they’re tinkering with building blocks of proteins, taking the first of many steps to develop a vaccine for the new coronavirus, SARS-CoV-2.

Creating a working vaccine is challenging and will likely take over a year, at best. But with Seattle at the heart of the coronavirus outbreak in the U.S. — as of March 13, the state had seen 568 cases and 37 deaths, numbers almost certain to rise as more people are tested — this task is the top priority for the scientists. “We’ve put a lot of projects on hold so that we can focus on this,” said Brooke Fiala, a vaccine researcher who leads the institute’s nanoparticle laboratory. 

Promising proteins designed on a computer are then tested in the lab at the University of Washington’s Institute for Protein Design. The coronavirus vaccine will consist of a nanoparticle, formed from many interlocking proteins.
Ian C Haydon/Institute for Protein Design

In order to fight the coronavirus, scientists from universities and drug companies around the world are developing vaccines, using a variety of methods. Some labs are manipulating the early stages of protein development, while others are working with dead versions of the virus. Fiala and her colleagues are taking a different approach: manufacturing nanoparticles to create a more efficient vaccine.

Vaccines expose the body to an antigen, which is a small dose of virus or bacteria parts. The antigens trigger an immune response: The body’s immune cells produce antibodies, which combat the invader and protect against further infection. There are several ways to create a vaccine. In one common method, for example, scientists weaken the virus so that it reproduces very poorly once inside the body, giving the immune system time to make antibodies.

In Fiala’s lab, scientists are instead attempting to form what is called a nanoparticle. The shape of this microscopic particle must allow for an antigen called a spike protein — the part of the SARS-CoV-2 virus that allows it to infect human cells — to fuse to the outside. If all the pieces fit together properly, the resulting molecule should look like a spiky ball, with the nanoparticle at the core and the spike proteins protruding outward. Once perfected, this spiky ball can become a vehicle for introducing the viral proteins to human cells and stimulating the immune system.

The first step in making a nanoparticle vaccine involves designing a promising nanoparticle model using a computer, manufacturing the DNA that codes for its shape, and then transferring that DNA into E. coli bacteria. The bacteria follow the DNA’s instructions to form the correct protein. Researchers then burst open the bacteria and extract the newly made protein, which spontaneously folds into the desired nanoparticle — each piece of the molecule exactly where it should be. Finally, multiple spike proteins are attached to the outside of the nanoparticle, creating the spiky ball. The immune system reads repetitive arrangements like this as a sign of peril and responds by rapidly creating antibodies.

This type of vaccine is thought to be more powerful than other varieties; the nanoparticle is highly effective at stabilizing the spike proteins and inducing an immune response. And while it’s been in use since around the 1980s, engineering a nanoparticle on a computer is a big step forward. “The use of computational models to predict and design self-assembling proteins is a recent breakthrough in nanoparticle vaccine design,” said Emma Kate Loveday, a virologist at Montana State University.

It’s a complicated process, but after a recent success in generating a nanoparticle vaccine for respiratory syncytial virus, a contagious respiratory infection, Fiala is hopeful. “We’ve become quite practiced,” she said. “We’re very used to this process of taking those antigens and putting them on nanoparticles.” So far, they have ordered 18 different nanoparticle DNA sequences and are confident that one of these variations will eventually lead to a successful vaccine. 

In the upcoming months, the team hopes to get a vaccine to animal trials. If all goes well, the vaccine will then be tested in humans. Making sure it’s safe and effective enough for widespread use could take a year or longer, though. Science often appears to move at a frustratingly slow rate, especially when something as serious as the coronavirus is spreading so quickly, said Ian Haydon, the scientific communications manager for the Institute of Protein Design. “But science like this needs to move slowly in order to make the proper drugs to save lives.”

Helen Santoro is an editorial fellow at High Country News. Email her at [email protected] or submit a letter to the editor.

High Country News Classifieds
  • FEATURES DIRECTOR - HIGH COUNTRY NEWS
    High Country News, an award-winning news organization covering the communities and environment of the Western United States, seeks a Features Director to join our editorial...
  • GENERAL MANAGER
    The Board of UYWCD seeks a new GM to manage operations & to implement our robust strategic plan. Details at www.upperyampawater.com. EOE
  • IN TUCSON, FOR SALE: A BEAUTIFUL, CLASSIC MID-CENTURY MODERN HOME
    designed by architect David Swanson in 1966. Located a block from Saguaro National Forest, yet minutes to Downtown and the UofA campus, 3706 sqft, 6...
  • EXECUTIVE DIRECTOR
    The Friends of the San Juans is seeking a new leader guide our efforts to protect and restore the San Juan Islands and the Salish...
  • 80 ACRES
    straddles North Platte Fishery, Wyoming. Legal access 2 miles off 1-80. Call 720-440-7633.
  • DIRECTOR OF PRODUCT AND MARKETING
    High Country News seeks a Director of Product and Marketing to join our senior team during an exciting chapter of innovation and growth. This individual...
  • OWN A THRIVING MOUNTAIN GUIDE SERVICE.
    Eastern Sierra guide service for sale to person with vision & expertise to take it onwards. Since 1995 with USFS & NPS permits. Ideal for...
  • IMPROVED LOT
    Private road, hillside, views. Well, pad, septic, 99 sq.ft. hut. Dryland permaculture orchard. Wildlife. San Diego--long growing season
  • UNIQUE INVESTMENT OPPORTUNITY
    Profitable off-the-grid business located 2 miles from Glacier National Park. Owner has 6 years operating experience. Seeking investor or partner for business expansion and enhancement....
  • REMOTE SITKA ALASKA FLOAT HOUSE VACATION RENTAL
    Vacation rental located in calm protected waters 8 miles from Sitka, AK via boat with opportunities to fish and view wildlife. Skiff rental also available.
  • EXPERT LAND STEWART
    Available for site conservator, property manager. View resume at http://skills.ojadigital.net.
  • CONSERVATIONIST? IRRIGABLE LAND?
    Stellar seed-saving NGO is available to serious partner. Package must include financial support. Details: http://seeds.ojaidigital.net.
  • CANYONLANDS FIELD INSTITUTE
    Colorado Plateau Natural & Human History Field Seminars. Lodge, river, hiking options. Small groups, guest experts.
  • WESTERN NATIVE SEED
    Specializing in native seeds and seed mixes for western states.
  • CHUCK BURR'S CULTUREQUAKE.COM BLOG
    Change will happen when we see a new way of living. Thinking to save the world.
  • COMING TO TUCSON?
    Popular vacation house, furnished, 2 bed/1 bath, yard, dog-friendly. Lee at [email protected] or 520-791-9246.
  • OJO CALIENTE COMMERCIAL VENTURE
    Outstanding location near the world famous Ojo Caliente Mineral Spring Resort. Classic adobe Mercantile complete w/living quarters, separate 6 unit B&B, metal building and spacious...